Development, Validation, and Subtype Analysis of a Predictive Model for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
A validated multiparametric CMR model can accurately predict AF risk in HCM patients, with subtype-specific predictors enabling personalized monitoring and early intervention.
Authors
- Hongming Yu (ORCID: https://orcid.org/0000-0002-8123-9958)
- Jing Xu (ORCID: https://orcid.org/0009-0000-4988-2145)
- Jing Liang (ORCID: https://orcid.org/0000-0002-1658-7761)
- Albert Shen (ORCID: https://orcid.org/0009-0008-5654-0002)
- Yuying Liu (ORCID: https://orcid.org/0009-0004-9737-3635)
- Xiuzheng Yue (ORCID: https://orcid.org/0000-0002-9090-9263)
- Qiucang Xue (ORCID: https://orcid.org/0009-0002-4358-896X)
- Dan Mu (ORCID: https://orcid.org/0000-0002-4860-2620)
Institutions
- Philips (Finland) (FI)
- Nanjing University of Information Science and Technology (CN)
- Nanjing University of Science and Technology (CN)
- Philips (China) (CN)
- Nanjing Drum Tower Hospital (CN)
- Shanghai Tenth People's Hospital (CN)
Publication Details
- Journal
- Reviews in Cardiovascular Medicine
- Published
- 2025-11-27
- DOI
- https://doi.org/10.31083/rcm45267
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Nanjing Drum Tower Hospital
- Nanjing Medical Science and Technique Development Foundation